2026 Policy Goals

The removal of Product Potency Limits will drive production costs related to cannabis concentrates and infused products down, leading to lower costs for patients. Removing Potency Limits would also increase product variability, allowing producers to craft true medicinal products like RSO for chronically ill patients.

Mississippi has one of the highest patient attrition rates of any medical cannabis program in the U.S., with roughly 37 patients falling out of the program for every 100 patients added. By extending the validity of a resident card, we hope to reduce patient attrition and extend access for rural patients.

Tens of thousands of our neighbors in bordering states visit Mississippi every day for work, education, and to care for family members. These visitors are often cannabis patients in their home states, here for extended periods. Mississippi's current nonresident card process is costly and cumbersome. By amending the process, nonresident patients will maintain access to their medicine during their time in Mississippi.

Many Mississippians with chronic or debilitating conditions are still without proper access to the MMCP due to the strict qualifying conditions list. After 3 years of program operations, the list has remained unchanged despite hundreds of requests from medical experts, operators, and patients. By adding "Right to Try" language to the Medical Cannabis Act, certifying practitioners will gain expanded discretion to treat their patients as they see fit.